| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |